Loading organizations...
§ Private Profile · Halifax, NS, Canada
Biopharmaceutical company developing anti-infective pharmaceuticals for unmet medical needs, focused on drugs, vaccines, and biodefense.
Appili Therapeutics is a biopharmaceutical company based in Halifax, Nova Scotia, that develops anti-infective drugs and vaccines to address unmet medical needs in severe infectious diseases and biodefense applications. The publicly traded firm operates a diverse clinical pipeline of treatments, including the liquid oral antibiotic LIKMEZ, which recently received United States FDA approval and is commercialized through a strategic manufacturing partnership with Saptalis Pharmaceuticals. To advance its specialized biodefense initiatives, the organization has successfully secured over $14 million in grant funding from the United States Department of Defense specifically for its tularemia vaccine development program. Following an initial $10.25 million public equity offering in 2020, the micro-cap biotechnology firm recently agreed to a proposed corporate acquisition by Aditxt valued at approximately $17 million CAD. The enterprise Appili Therapeutics was originally founded in 2015 by Kevin Sullivan.
Appili Therapeutics has raised $16.9M across 7 funding rounds.
Appili Therapeutics has raised $16.9M in total across 7 funding rounds.
Appili Therapeutics has raised $16.9M across 7 funding rounds. Most recently, it raised $360K Debt in April 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 10, 2019 | $360K Debt Financing | Navdeep Bains | — | Announced |
| Feb 7, 2018 | $4.8M Debt Financing | — | Andy Fillmore, Innovacorp | Announced |
| Oct 23, 2017 | $3.1M Venture Round | Lidija Marusic | — | Announced |
| Apr 11, 2017 | $400K Venture Round | — | — | Announced |
| Feb 17, 2017 | $2.8M Venture Round | Atlantic Canada Opportunities Agency | — | Announced |
| Dec 21, 2016 | $2.1M Venture Round | — | Lidija Marusic | Announced |
| May 25, 2016 | $3.3M Seed | — | Navdeep Bains, Lidija Marusic | Announced |
Appili Therapeutics has raised $16.9M in total across 7 funding rounds.
Appili Therapeutics's investors include Navdeep Bains, Andy Fillmore, Innovacorp, Lidija Marusic, Atlantic Canada Opportunities Agency.